Follicular Lymphoma
Fourteen months ago I profiled Biovest and the company's innovative therapeutic
Follicular lymphoma is classified as a
You've just finished six rounds of tough CHOP combination chemotherapy plus the
Today I'm very pleased to be writing about a movement to
Swiss pharmaceutical giant Roche announced on Wednesday that a late-stage study
FDA Approves Zevalin® Expanded Label as Part of First-Line Therapy in Treatment of Follicular
Patients with previously untreated follicular lymphoma
An exhaustive study by the Mayo Clinic involving 35,
Earlier this month, the biopharmaceutical company Biovest
Results of a new study could have major implications for patients with follicular
Follicular lymphoma remains an incurable subtype, and it is especially difficult to
This article looks at the survival rate for Follicular lymphoma
Determining which follicular lymphoma treatment options to go with—and when to go with them—is
Follicular lymphoma is an indolent B-cell subtype of non-Hodgkin's lymphoma (NHL). It is the
